retatrutide phase 2 trial weight loss 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No plateau — curve still descending Retatrutide: A Promising Option for

Patients should confirm with their own insurer whether any reimbursement may be available under their specific plan

Advise reporting persistent abdominal pain (pancreatitis warning)

If you miss a dose for more than 4 days, skip the missed dose

Most specialists recommend reducing your Zepbound dose by 25% every 34 weeks, monitoring appetite and weight at each step

Alters SE, McLaughlin B, Spink B, Lachinyan T, Wang CW, Podust V, Schellenberger V, Stemmer WPC (2012) GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohns disease model

Sleep is one of the most underrated ways to improve our health